Miriam Fuchs
Senior Associate
Miriam Fuchs
Senior Associate
“It is very good to work with her. She is accurate and responds quickly.”
– Chambers Europe
About Miriam Fuchs
Miriam Fuchs is a member of the Corporate/M&A team with a special focus on Life Sciences & Healthcare. She’s been involved in all types of pharmaceutical matters, mainly advising on complex regulatory issues concerning over-the-counter medicines, prescription-only medicines, medical aids, cosmetics, medical devices and food supplements. Miriam has extensive legal experience in clinical trials, categorization of medical devices and reimbursement of medical aids and medicinal products. She frequently advises on compliance with local laws and codes of conduct, therefore she also regularly provides trainings to clients on these issues. In addition to the above, Miriam also provides commercial advice to her clients on a daily basis. She has experience in representing clients in product liability, product recall cases and proceedings before regulatory bodies and authorities. Prior to joining Wolf Theiss, Miriam co-developed and co-lead the Hungarian life sciences practice of an international law firm which achieved international recognition.
Education
Eötvös Loránd University, Budapest (J.D.), 2011
Languages
Hungarian, English
Related insights
Life Sciences Bulletin: Hungarian Medicines Authority resumes investigations into pharma promotions
The Hungarian National Centre for Public Health and Pharmacy (NNGYK or the Authority) has issued its first decision in mor...
Read more
American Industrial Partners to acquire AGCO Corporation’s Grain & Protein division with M&A and regulatory support from Wolf Theiss
Vienna, Prague, Budapest, 7 August 2024 – Wolf Theiss advises American Industrial Partners (AIP), a global industrials i...
Read more
Life Sciences Bulletin: New public foundation to oversee exceptional drug funding in Hungary as of 2025
Commencing in 2025, the Batthyány-Strattmann László Foundation will assume the responsibility of managing applications ...
Read more
Life Sciences Bulletin: CJEU ruling on the online sale of OTC medicines may impact Hungarian market
The recent judgement of the Court of Justice of the European Union (“CJEU”) on the sale of over-the-counter (O...
Read more
Hungarian legislation reform related to centralised procurement for institutional pharmacies
The governmental decree published on 22 February (No. 33/2024 (II. 22.)) sets forth the establishment of a new project com...
Read more